Ligand Pharmaceuticals Incorporated (LGND) — Cash Flow-to-Debt Ratio
Ligand Pharmaceuticals Incorporated (LGND) has a Cash Flow-to-Debt Ratio of 0.09x as of March 2026, meaning its operating cash flow of $48.69 Million could theoretically repay 0% of its total liabilities ($534.78 Million) in one year. See LGND free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ligand Pharmaceuticals Incorporated Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Ligand Pharmaceuticals Incorporated across 32 annual periods. Also explore Ligand Pharmaceuticals Incorporated net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ligand Pharmaceuticals Incorporated (1994–2025)
Year-by-year debt coverage analysis for Ligand Pharmaceuticals Incorporated. For market capitalisation and broader financial context, see Ligand Pharmaceuticals Incorporated (LGND) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | $49.36 Million | $543.42 Million | ▼ -89.6% |
| 2024 | 0.87x | $97.05 Million | $111.33 Million | ▲ +51.7% |
| 2023 | 0.57x | $49.58 Million | $86.30 Million | ▼ -31.2% |
| 2022 | 0.83x | $137.85 Million | $165.18 Million | ▲ +404.6% |
| 2021 | 0.17x | $78.80 Million | $476.43 Million | ▲ +97.8% |
| 2020 | 0.08x | $54.59 Million | $652.76 Million | ▲ +307.4% |
| 2019 | -0.04x | $-29.34 Million | $727.68 Million | ▼ -114.5% |
| 2018 | 0.28x | $194.06 Million | $699.89 Million | ▼ -25.2% |
| 2017 | 0.37x | $93.57 Million | $252.37 Million | ▲ +35.8% |
| 2016 | 0.27x | $63.00 Million | $230.73 Million | ▲ +50.2% |
| 2015 | 0.18x | $41.73 Million | $229.54 Million | ▲ +106.5% |
| 2014 | 0.09x | $20.57 Million | $233.62 Million | ▼ -76.6% |
| 2013 | 0.38x | $20.69 Million | $55.10 Million | ▲ +18039.4% |
| 2012 | 0.00x | $161.00K | $77.78 Million | ▲ +120.1% |
| 2011 | -0.01x | $-1.17 Million | $113.70 Million | ▲ +96.9% |
| 2010 | -0.33x | $-27.07 Million | $82.55 Million | ▼ -6.7% |
| 2009 | -0.31x | $-33.80 Million | $109.95 Million | ▼ -171.0% |
| 2008 | -0.11x | $-20.62 Million | $181.81 Million | ▲ +83.3% |
| 2007 | -0.68x | $-97.73 Million | $144.16 Million | ▼ -46.2% |
| 2006 | -0.46x | $-138.52 Million | $298.70 Million | ▼ -2456.4% |
| 2005 | 0.02x | $8.37 Million | $425.04 Million | ▲ +39.5% |
| 2004 | 0.01x | $5.75 Million | $407.78 Million | ▲ +1087.2% |
| 2003 | 0.00x | $274.00K | $230.53 Million | ▲ +100.9% |
| 2002 | -0.13x | $-25.11 Million | $196.59 Million | ▼ -12.5% |
| 2001 | -0.11x | $-19.91 Million | $175.35 Million | ▲ +59.6% |
| 2000 | -0.28x | $-47.35 Million | $168.55 Million | ▲ +25.6% |
| 1999 | -0.38x | $-60.50 Million | $160.20 Million | ▲ +5.1% |
| 1998 | -0.40x | $-66.60 Million | $167.40 Million | ▼ -117.0% |
| 1997 | -0.18x | $-13.40 Million | $73.10 Million | ▲ +62.8% |
| 1996 | -0.49x | $-33.30 Million | $67.60 Million | ▲ +14.9% |
| 1995 | -0.58x | $-37.90 Million | $65.50 Million | ▲ +17.5% |
| 1994 | -0.70x | $-14.30 Million | $20.40 Million | — |